Niagen Bioscience's total assets for Q1 2026 were $114.33M, an increase of 7.45% from the previous quarter. NAGE total liabilities were $32.00M for the fiscal quarter, a 7.12% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.